Introduction Mild Cognitive Impairment (MCI) affects millions in the UK and Europe, presenting as memory lapses, difficulty focusing, and challenges in problem-solving. Often, MCI is a precursor to dementia or Alzheimer’s disease. Conventional medications provide only limited relief, prompting researchers and caregivers to explore alternative approaches that can support cognitive health. Psychedelic compounds such as […]
Introduction Cognitive decline is a growing concern in the UK and Europe, affecting millions of individuals as they age. From mild cognitive impairment (MCI) to dementia and Alzheimer’s disease, neurodegenerative disorders gradually erode memory, attention, and problem-solving abilities. Traditional treatments often offer limited symptom relief, which has driven interest in alternative therapies that may support […]
Introduction Alzheimer’s disease remains one of the most challenging neurodegenerative disorders in the UK and Europe. It gradually impairs memory, cognition, and daily functioning, affecting millions of families emotionally and financially. While traditional pharmaceutical approaches provide limited symptom relief, emerging research suggests that alternative therapies, particularly psychedelic compounds like psilocybin from magic mushrooms and Ibogaine […]